SATB2 promotes EMT-like, invasive, and endothelial tube-promoting phenotypes with the involvement of ZEB1 in 8305C anaplastic thyroid cancer cells
European Journal of Histochemistry · 2026-11-04 · 70 (4)
DOI: 10.4081/ejh.2026.4738 ↗Abstract
Anaplastic thyroid cancer (ATC) exhibits marked dedifferentiation, rapid invasion, and limited therapeutic responsiveness. This study investigated associations between SATB2, ZEB1, EMT-like changes, invasion, short-term vemurafenib response, and endothelial tube-promoting activity in 8305C cells as an in vitro proof-of-concept model. SATB2 was overexpressed or silenced, followed by reciprocal ZEB1 manipulation to assess its contribution to SATB2-associated phenotypes. Expression was assessed by quantitative real-time PCR, Western blotting, and immunofluorescence. ChIP-qPCR examined SATB2 enrichment at a selected ZEB1 promoter region. Transwell assays assessed invasion, and Western blotting evaluated EMT- and angiogenesis-associated proteins. Short-term vemurafenib responses were measured using CCK-8 concentration–response assays. Supernatant VEGFA concentrations were determined by ELISA, and conditioned media were tested in HUVEC tube-formation assays. SATB2 manipulation produced concordant changes in ZEB1 mRNA and protein expression. ChIP-qPCR demonstrated significant SATB2 enrichment at the examined ZEB1 promoter region relative to IgG, indicating association without establishing direct transcriptional activation. SATB2 overexpression increased invasion, decreased E-cadherin, and increased Vimentin, VEGFA, and PDGF-BB expression; silencing produced opposite changes. SATB2 overexpression shifted the short-term vemurafenib concentration-response curve toward a higher IC50, whereas silencing shifted it toward a lower IC50. Reciprocal ZEB1 manipulation attenuated molecular and functional changes associated with SATB2 gain- or loss-of-function, supporting ZEB1 involvement. Conditioned medium from SATB2-overexpressing cells promoted HUVEC tube formation, which was attenuated by ZEB1 silencing. In 8305C cells, SATB2 was associated with ZEB1 expression, EMT-like remodeling, invasion, altered short-term vemurafenib response, and endothelial tube-promoting activity. Reciprocal ZEB1 manipulation supports its involvement in these phenotypes, but ChIP-qPCR does not establish direct SATB2-mediated transcriptional activation of ZEB1. Findings are limited to a single ATC cell-line model and require validation in additional experimental models.
EUVIMED